Approach to Sustainability
We have formulated a basic sustainability policy based on the Group principles.
the Alfresa Group's Basic Sustainability Policy
We create and deliver a fresh life for all.
We believe it is important to realize a sustainable society in order to create
and deliver a fresh life for all.
We aim to contribute to the development of a society in which everyone can live in good health, while at the same time
increasing our corporate value in a sustainable manner,
by conducting business activities based on the Alfresa Group’s principles
and by addressing social and environmental issues.
Conceptual diagram of sustainability management
Based on the Alfresa Group’s Principles and its Basic Sustainability Policy, we work together as one in the eight important sustainability issues through its business activities in line with each policy and guideline that the Group formulated.
CSR Promotion Structure
The Group established the CSR Promotion Committee to promote CSR activities throughout the Group. As an advisory body to the representative director, the committee works to promote these activities in accordance with the Alfresa Group’s Basic Sustainability Policy determined by the Board of Directors. To fulfill this role, the committee looks into policies related to Groupwide CSR activities, creates reports, and conducts evaluations of CSR activities of Group companies that are then reported in summary on a regular basis (twice a year) to the representative director and the Board of Directors.
Alfresa Group CSR Management Framework
Participation in Industry Groups and External Organizations
The Alfresa Group aims to become a Healthcare Consortium that provides products and services in every health-related field, and actively participates in various industry groups and external organizations.
Main Industry Groups and External Organizations
- Keidanren (Japan Business Federation), Corporate Member
- The Federation of Japan Pharmaceutical Wholesalers Association (JPWA), Member
- Japan Association for the World Food Programme, Councilor
Communicating with Stakeholders
The Group will steadily promote CSR activities by having all of its people properly understand and implement the Group’s principles in the form of Our Philosophy, Our Vision, and Our Promises, while practicing two-way communication with its various stakeholders.
|Main means of communication
|Customers and Suppliers
|Serving as a bridge between customers and suppliers, the Group collects information about pharmaceuticals (efficacy and side effects) as well as opinions and requests from customers, and then provides this information to suppliers. The Group also holds seminars and events on themes that are useful for customers and suppliers respectively to provide opportunities for solving health and healthcare-related issues and sharing information.
|The Group shares information through the Group newsletter and other tools, and implements Group-wide initiatives to spread and ensure the practice of the Group’s principles.
|The Group strives to reduce environmental impact at each stage, including the manufacturing, selling and disposing of pharmaceuticals and other products, and it fully discloses information on its environmental impact.
|The Group is aware of its social responsibilities as a corporate citizen that exists in and develops together with society. In addition to contributing to healthcare in the society through its business activities with close links to local communities, it conducts social contribution activities proactively, aiming for harmonious coexistence with local communities.
|Shareholders and Investors
|In order to deliver the appropriate information to all shareholders and investors, we provide timely disclosure of information, practicing the general principles of transparency, fairness, continuity, timeliness, and interactivity.
|Governments (National and Local Governments), Industry Groups
|The Group complies with laws and regulations, including the Act on Securing Quality, Efficacy and Safety of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics (PMD Act) and conducts itself in accordance with the Fair Competition Code of the healthcare-related industry. The Group pays its taxes properly and in a timely manner.